Drug Chatter -- Tracking biopharma stock chatter

Profile for Alkermes plc (ALKS)

« Back to company index

ALKS Chatter Timeline

Stock Ticker for ALKS

Most Active Tweeters for ALKS

UserTweets
@biotech_sector 6
@pharma_sector 6
@emq_news 4
@SPNewsAnalysis 4
@IRAMarketReport 4

Recent Tweets for ALKS

TheMarketsDaily @TheMarketsDaily
Globeflex Capital L P Has $1.39 Million Holdings in Alkermes PLC $ALKS https://t.co/DQEmDLvV3P
September 25th 2017, 10:09am
dailypoliticaln @dailypoliticaln
Alkermes PLC $ALKS Earning Somewhat Favorable News Coverage, Analysis Shows https://t.co/4tn2doMowN
September 24th 2017, 4:09am
WKRBNews @WKRBNews
Alkermes PLC $ALKS Earning Somewhat Favorable News Coverage, Analysis Shows https://t.co/uUZEo7T4aS
September 24th 2017, 4:09am
dailymailtimes @dailymailtimes
Alkermes PLC $ALKS Earning Somewhat Favorable News Coverage, Analysis Shows https://t.co/5Y7bdem2Ci
September 24th 2017, 4:09am
midetimes @midetimes
Alkermes PLC $ALKS Earning Somewhat Favorable News Coverage, Analysis Shows https://t.co/2CTyaSY5yP
September 24th 2017, 4:09am
botpicks @botpicks
Should I Go Long or Short $ALKS ?
September 24th 2017, 3:09am
CFinancialNews @CFinancialNews
Contrasting Alkermes PLC $ALKS & Nabriva Therapeutics AG $NBRV https://t.co/Lb58B96NAY
September 23rd 2017, 6:09pm
IRAMarketReport @IRAMarketReport
Contrasting Alkermes PLC $ALKS & Nabriva Therapeutics AG $NBRV https://t.co/19gxsL8Pyu
September 23rd 2017, 6:09pm
chaffeybreeze @chaffeybreeze
Contrasting Alkermes PLC $ALKS & Nabriva Therapeutics AG $NBRV https://t.co/500r2XCAzk
September 23rd 2017, 6:09pm
intercooleronli @intercooleronli
Contrasting Alkermes PLC $ALKS & Nabriva Therapeutics AG $NBRV https://t.co/6xFbpHrJdD
September 23rd 2017, 6:09pm
TickerReport @TickerReport
BlackRock Inc. Has $592.38 Million Position in Alkermes PLC $ALKS https://t.co/HEjgHrdoGK
September 23rd 2017, 9:09am
emq_news @emq_news
BlackRock Inc. Has $592.38 Million Position in Alkermes PLC $ALKS https://t.co/wvImFM3IEv
September 23rd 2017, 9:09am
TickerReport @TickerReport
BlackRock Inc. Has $592.38 Million Position in Alkermes PLC $ALKS https://t.co/XQqvT1Yc34
September 23rd 2017, 9:09am
SleekMoneycom @SleekMoneycom
UBS Asset Management Americas Inc. Decreases Holdings in Alkermes PLC $ALKS https://t.co/ch4qSOuRVc
September 23rd 2017, 9:09am
noritsunagirota @noritsunagirota
Alkermes Plc $ALKS Shareholder Rock Springs Capital Management LP Cut Position as Shares Rose ...
September 23rd 2017, 5:09am
SPNewsAnalysis @SPNewsAnalysis
Alkermes PLC $ALKS Holdings Boosted by Fmr LLC https://t.co/oUCh9ntZkj
September 22nd 2017, 11:09am
IRAMarketReport @IRAMarketReport
Alkermes PLC $ALKS Shares Bought by Van ECK Associates Corp https://t.co/c5aPUOrGtT
September 22nd 2017, 9:09am
chaffeybreeze @chaffeybreeze
Alkermes PLC $ALKS Shares Bought by Van ECK Associates Corp https://t.co/Q9j7Oyf4FA
September 22nd 2017, 9:09am
SPNewsAnalysis @SPNewsAnalysis
ProShare Advisors LLC Sells 2,830 Shares of Alkermes PLC $ALKS https://t.co/75JnCRQYdG
September 22nd 2017, 8:09am
storminvestor @storminvestor
ProShare Advisors LLC Sells 2,830 Shares of Alkermes PLC $ALKS https://t.co/FdSKVfvEx7
September 22nd 2017, 8:09am
dakotafinancial @dakotafinancial
Alkermes PLC $ALKS Stake Increased by Neuberger Berman Group LLC https://t.co/l4FrvMHRIn
September 22nd 2017, 5:09am
chaffeybreeze @chaffeybreeze
Alkermes PLC $ALKS Shares Bought by Amalgamated Bank https://t.co/H3pYX22qYT
September 20th 2017, 9:09am
IRAMarketReport @IRAMarketReport
Alkermes PLC $ALKS Shares Bought by Amalgamated Bank https://t.co/voJ9jGtGYC
September 20th 2017, 9:09am
wosaikeneriki @wosaikeneriki
Alkermes Plc $ALKS Shareholder Baker Bros Advisors LP Has Trimmed Holding as Stock Price Rose ...
September 20th 2017, 6:09am
biotech_sector @biotech_sector
#Alkermes' ARISTADA Shows Better Results to Treat Schizophrenia. Read more: https://t.co/IkjuVaxozR $ALKS
September 19th 2017, 11:09am
pharma_sector @pharma_sector
#Alkermes' ARISTADA Shows Better Results to Treat Schizophrenia. Read more: https://t.co/x9g3H89TRC $ALKS
September 19th 2017, 11:09am
emq_news @emq_news
Alkermes PLC $ALKS Shares Sold by Westfield Capital Management Co. LP https://t.co/8ZOJCBwPNh
September 19th 2017, 10:09am
confcalltran @confcalltran
Alkermes plc's EVP/CAO/CCO Alks Inc, Sec ALKS just picked up 4,087 shares https://t.co/xLazpjmtse $ALKS
September 18th 2017, 6:09pm
InsiderAlertsIA @InsiderAlertsIA
$ALKS: New Insider Filing on SVP, CLO, Alkermes, Inc. DAVID JOSEPH GAFFIN: https://t.co/OOP3QAlctB
September 18th 2017, 5:09pm
WarrenofWallSt @WarrenofWallSt
#Alkermes $ALKS is looking a bit expensive by my calculations https://t.co/F7ubemc8HR https://t.co/xhQc0zOzKj
September 18th 2017, 4:09pm
pharma_sector @pharma_sector
Patients Switched To #Alkermes??? ARISTADA Showed Significant Improvement In Schizophrenia ... Read more: https://t.co/jqyqDY3cDP $ALKS
September 18th 2017, 10:09am
biotech_sector @biotech_sector
Patients Switched To #Alkermes??? ARISTADA Showed Significant Improvement In Schizophrenia ... Read more: https://t.co/5fVxiM3YM2 $ALKS
September 18th 2017, 10:09am
tranbryannguyen @tranbryannguyen
RT @BioStocks: $ALKS announces positive topline results from phase 4 study of ARISTADA for the treatment of schizophrenia. https://t.co/Okx…
September 18th 2017, 9:09am
Briefingcom @Briefingcom
$ALKS: Alkermes presents 'positive' topline results from a phase 4 clinical study of ARISTADA extended-release... https://t.co/dnKyYbRc82
September 18th 2017, 9:09am
OpenOutcrier @OpenOutcrier
$ALKS (+0.0% pre) Patients Switched to ARISTADA® Showed Significant Improvement in Schizophrenia Symptoms - BW https://t.co/q35PcACjjZ
September 18th 2017, 8:09am
realmaciej @realmaciej
RT @DrSManian: $ALKS ++ https://t.co/Htneq1PBd1
September 18th 2017, 8:09am
DrSManian @DrSManian
$ALKS ++ https://t.co/Htneq1PBd1
September 18th 2017, 8:09am
realmaciej @realmaciej
RT @odibro: $ALKS Patients Switched to ARISTADA® Showed Significant Improvement in Schizophrenia Symptoms https://t.co/NMPKUhq9vo
September 18th 2017, 7:09am
biotech_sector @biotech_sector
Patients Switched to #Alkermes' ARISTADA Showed Significant Improvement in Schizophrenia Sy... Read more: https://t.co/X5GKXWPgnp $ALKS
September 18th 2017, 7:09am
pharma_sector @pharma_sector
Patients Switched to #Alkermes' ARISTADA Showed Significant Improvement in Schizophrenia Sy... Read more: https://t.co/0Sfmznltkk $ALKS
September 18th 2017, 7:09am
stocknewsdotcom @stocknewsdotcom
$ALKS Presents 'positive' top-line results from a phase 4 clinical study of ARISTADA extended-release injectable… https://t.co/ig4Vj290JH
September 18th 2017, 7:09am
biotech_sector @biotech_sector
#Alkermes Partnering Deals and Alliances 2010 to 2017 Report Updated 01092017 Prices from U... Read more: https://t.co/yiqjCD38la $ALKS
September 18th 2017, 7:09am
pharma_sector @pharma_sector
#Alkermes Partnering Deals and Alliances 2010 to 2017 Report Updated 01092017 Prices from U... Read more: https://t.co/vboFsSJTqf $ALKS
September 18th 2017, 7:09am
biotech_sector @biotech_sector
Patients Switched to #Alkermes ARISTADAÂ Showed Significant Improvement in Schizophrenia Sy... Read more: https://t.co/dBQ3Ro56fm $ALKS
September 18th 2017, 7:09am
pharma_sector @pharma_sector
Patients Switched to #Alkermes ARISTADAÂ Showed Significant Improvement in Schizophrenia Sy... Read more: https://t.co/OnUmat8FQ1 $ALKS
September 18th 2017, 7:09am
BioStocks @BioStocks
$ALKS announces positive topline results from phase 4 study of ARISTADA for the treatment of schizophrenia. https://t.co/Okx9lJDGr3
September 18th 2017, 7:09am
stockboardinc @stockboardinc
$ALKS Patients Switched to Alkermes’ ARISTADA® Showed Significant Improvement in Schizophrenia Symptoms... - https://t.co/BQjiB4Ibc2
September 18th 2017, 7:09am
odibro @odibro
$ALKS Patients Switched to ARISTADA® Showed Significant Improvement in Schizophrenia Symptoms https://t.co/NMPKUhq9vo
September 18th 2017, 7:09am
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
Patients Switched $ALKS ARISTADA® Showed Significant Improvement in Schizophrenia Symptoms After Inade Response or… https://t.co/bm3u8zFb07
September 18th 2017, 7:09am
Allstocknews @Allstocknews
$ALKS Patients Switched to Alkermes' ARISTADA® Showed Significant Improvement in Schizophrenia Symptoms After From our Stock News Alerts App
September 18th 2017, 7:09am

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.